Global and United States Cancer Drug Therapy Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Cancer Drug Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Drug Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Drug Therapy market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Cancer Drug Therapy market has been segmented into Targeted Therapy, Chemotherapy, Immunotherapy, etc.
Breakdown by Application, Cancer Drug Therapy has been segmented into Angiogenesis Inhibitors, mTOR Inhibitors, Monoclonal Antibodies, Cytokine Immunotherapy (IL-2), etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Drug Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Drug Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Drug Therapy market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Cancer Drug Therapy Market Share Analysis
Cancer Drug Therapy competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Cancer Drug Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Drug Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Drug Therapy are: Amgen / Allergan, Merck, Aveo Pharmaceuticals, Argos Therapeutics, Incyte, AstraZeneca, Bristol-Myers Squibb, Exelixis, Bayer, Roche, Pfizer, Eisai, Prometheus Labs, Novartis, Exelixis, Genentech (Roche), etc. Among other players domestic and global, Cancer Drug Therapy market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Cancer Drug Therapy market are listed below:
Amgen / Allergan
Merck
Aveo Pharmaceuticals
Argos Therapeutics
Incyte
AstraZeneca
Bristol-Myers Squibb
Exelixis
Bayer
Roche
Pfizer
Eisai
Prometheus Labs
Novartis
Exelixis
Genentech (Roche)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Targeted Therapy
Chemotherapy
Immunotherapy
Market segment by Application, can be divided into
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Table of Contents
1 Market Overview
1.1 Cancer Drug Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Drug Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Drug Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Angiogenesis Inhibitors
1.3.3 mTOR Inhibitors
1.3.4 Monoclonal Antibodies
1.3.5 Cytokine Immunotherapy (IL-2)
1.4 Global Cancer Drug Therapy Market Size and Forecast (2015-2025)
1.4.1 Global Cancer Drug Therapy Revenue and Forecast (2015-2025)
1.4.2 Global Cancer Drug Therapy Sales and Forecast (2015-2025)
1.5 Global Cancer Drug Therapy Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Amgen / Allergan
2.1.1 Amgen / Allergan Details
2.1.2 Amgen / Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen / Allergan SWOT Analysis
2.1.4 Amgen / Allergan Product and Services
2.1.5 Amgen / Allergan Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aveo Pharmaceuticals
2.3.1 Aveo Pharmaceuticals Details
2.3.2 Aveo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aveo Pharmaceuticals SWOT Analysis
2.3.4 Aveo Pharmaceuticals Product and Services
2.3.5 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Argos Therapeutics
2.4.1 Argos Therapeutics Details
2.4.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Argos Therapeutics SWOT Analysis
2.4.4 Argos Therapeutics Product and Services
2.4.5 Argos Therapeutics Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Incyte
2.5.1 Incyte Details
2.5.2 Incyte Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Incyte SWOT Analysis
2.5.4 Incyte Product and Services
2.5.5 Incyte Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bristol-Myers Squibb SWOT Analysis
2.7.4 Bristol-Myers Squibb Product and Services
2.7.5 Bristol-Myers Squibb Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Exelixis
2.8.1 Exelixis Details
2.8.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Exelixis SWOT Analysis
2.8.4 Exelixis Product and Services
2.8.5 Exelixis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Roche SWOT Analysis
2.10.4 Roche Product and Services
2.10.5 Roche Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer SWOT Analysis
2.11.4 Pfizer Product and Services
2.11.5 Pfizer Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eisai
2.12.1 Eisai Details
2.12.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eisai SWOT Analysis
2.12.4 Eisai Product and Services
2.12.5 Eisai Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Prometheus Labs
2.13.1 Prometheus Labs Details
2.13.2 Prometheus Labs Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Prometheus Labs SWOT Analysis
2.13.4 Prometheus Labs Product and Services
2.13.5 Prometheus Labs Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Novartis SWOT Analysis
2.14.4 Novartis Product and Services
2.14.5 Novartis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Exelixis
2.15.1 Exelixis Details
2.15.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Exelixis SWOT Analysis
2.15.4 Exelixis Product and Services
2.15.5 Exelixis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Genentech (Roche)
2.16.1 Genentech (Roche) Details
2.16.2 Genentech (Roche) Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Genentech (Roche) SWOT Analysis
2.16.4 Genentech (Roche) Product and Services
2.16.5 Genentech (Roche) Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Cancer Drug Therapy Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Cancer Drug Therapy Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Cancer Drug Therapy Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Cancer Drug Therapy Sales in United States (2018-2019)
3.2.2 United States Cancer Drug Therapy Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Drug Therapy Manufacturer Market Share in 2019
3.3.2 Top 6 Cancer Drug Therapy Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Cancer Drug Therapy Market Size by Geography (2015-2020)
4.1.1 Global Cancer Drug Therapy Sales by Geography (2015-2020)
4.1.2 Global Cancer Drug Therapy Revenue by Regions (2015-2020)
4.2 Global Cancer Drug Therapy Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Cancer Drug Therapy Sales and Forecast by Regions (2020-2025)
4.2.2 Global Cancer Drug Therapy Revenue and Forecast by Regions (2020-2025)
4.3 North America Cancer Drug Therapy Market Size and Forecast (2015-2025)
4.4 Europe Cancer Drug Therapy Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Cancer Drug Therapy Market Size and Forecast (2015-2025)
4.6 South America Cancer Drug Therapy Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Cancer Drug Therapy Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Cancer Drug Therapy Market Size by Country (2015-2020)
5.1.1 North America Cancer Drug Therapy Sales and Market Share by Country (2015-2020)
5.1.2 North America Cancer Drug Therapy Revenue and Market Share by Country (2015-2020)
5.2 North America Cancer Drug Therapy Market Size and Forecast by Country (2020-2025)
5.2.1 North America Cancer Drug Therapy Sales and Forecast by Country (2020-2025)
5.2.2 North America Cancer Drug Therapy Revenue and Forecast by Country (2020-2025)
5.3 United States Cancer Drug Therapy Market Size and Forecast (2015-2025)
5.4 Canada Cancer Drug Therapy Market Size and Forecast (2015-2025)
5.5 Mexico Cancer Drug Therapy Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Cancer Drug Therapy Market Size by Country (2015-2020)
6.1.1 Europe Cancer Drug Therapy Sales by Country (2015-2020)
6.1.2 Europe Cancer Drug Therapy Revenue by Country (2015-2020)
6.2 Europe Cancer Drug Therapy Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Cancer Drug Therapy Sales and Forecast by Country (2020-2025)
6.2.2 Europe Cancer Drug Therapy Revenue and Forecast by Country (2020-2025)
6.3 Germany Cancer Drug Therapy Market Size and Forecast (2015-2025)
6.4 United Kingdom Cancer Drug Therapy Market Size and Forecast (2015-2025)
6.5 France Cancer Drug Therapy Market Size and Forecast (2015-2025)
6.6 Russia Cancer Drug Therapy Market Size and Forecast (2015-2025)
6.7 Italy Cancer Drug Therapy Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cancer Drug Therapy Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Cancer Drug Therapy Sales by Region (2015-2020)
7.1.2 Asia-Pacific Cancer Drug Therapy Revenue by Region (2015-2020)
7.2 Asia-Pacific Cancer Drug Therapy Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Cancer Drug Therapy Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Cancer Drug Therapy Revenue and Forecast by Region (2020-2025)
7.3 China Cancer Drug Therapy Market Size and Forecast (2015-2025)
7.4 Japan Cancer Drug Therapy Market Size and Forecast (2015-2025)
7.5 Korea Cancer Drug Therapy Market Size and Forecast (2015-2025)
7.6 India Cancer Drug Therapy Market Size and Forecast (2015-2025)
7.7 Southeast Asia Cancer Drug Therapy Market Size and Forecast (2015-2025)
7.8 Australia Cancer Drug Therapy Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Cancer Drug Therapy Market Size by Country (2015-2020)
8.1.1 South America Cancer Drug Therapy Sales by Country (2015-2020)
8.1.2 South America Cancer Drug Therapy Revenue by Country (2015-2020)
8.2 South America Cancer Drug Therapy Market Size and Forecast by Country (2020-2025)
8.2.1 South America Cancer Drug Therapy Sales and Forecast by Country (2020-2025)
8.2.2 South America Cancer Drug Therapy Revenue and Forecast by Country (2020-2025)
8.3 Brazil Cancer Drug Therapy Market Size and Forecast (2015-2025)
8.4 Argentina Cancer Drug Therapy Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cancer Drug Therapy Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Cancer Drug Therapy Sales by Country (2015-2020)
9.1.2 Middle East & Africa Cancer Drug Therapy Revenue by Country (2015-2020)
9.2 Middle East & Africa Cancer Drug Therapy Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Cancer Drug Therapy Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Cancer Drug Therapy Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Cancer Drug Therapy Market Size and Forecast (2015-2025)
9.4 Turkey Cancer Drug Therapy Market Size and Forecast (2015-2025)
9.5 Egypt Cancer Drug Therapy Market Size and Forecast (2015-2025)
9.6 South Africa Cancer Drug Therapy Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Cancer Drug Therapy Market Size by Type (2015-2020)
10.1.1 Global Cancer Drug Therapy Sales by Type (2015-2020)
10.1.2 Global Cancer Drug Therapy Revenue by Type (2015-2020)
10.1.3 Global Cancer Drug Therapy Price by Type (2015-2020)
10.2 Global Cancer Drug Therapy Market Size and Forecast by Type (2020-2025)
10.2.1 Global Cancer Drug Therapy Sales and Forecast by Type (2020-2025)
10.2.2 Global Cancer Drug Therapy Revenue and Forecast by Type (2020-2025)
10.2.3 Global Cancer Drug Therapy Price and Forecast by Type (2020-2025)
10.3 United States Cancer Drug Therapy Market Size and Forecast by Type (2015-2025)
10.3.1 United States Cancer Drug Therapy Market Size by Type (2015-2020)
10.3.2 United States Cancer Drug Therapy Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Cancer Drug Therapy Market Size by Application (2015-2020)
11.1.1 Global Cancer Drug Therapy Sales by Application (2015-2020)
11.1.2 Global Cancer Drug Therapy Revenue by Application (2015-2020)
11.1.3 Global Cancer Drug Therapy Price by Application (2015-2020)
11.2 Global Cancer Drug Therapy Market Size and Forecast by Application (2020-2025)
11.2.1 Global Cancer Drug Therapy Sales and Forecast by Application (2020-2025)
11.2.2 Global Cancer Drug Therapy Revenue and Forecast by Application (2020-2025)
11.2.3 Global Cancer Drug Therapy Price and Forecast by Application (2020-2025)
11.3 United States Cancer Drug Therapy Market Size and Forecast by Application (2015-2025)
11.3.1 United States Cancer Drug Therapy Market Size by Application (2015-2020)
11.3.2 United States Cancer Drug Therapy Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Cancer Drug Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Drug Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Drug Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Cancer Drug Therapy Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Amgen / Allergan Basic Information, Manufacturing Base and Competitors
Table 6. Amgen / Allergan Cancer Drug Therapy Major Business
Table 7. Amgen / Allergan Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 8. Amgen / Allergan SWOT Analysis
Table 9. Amgen / Allergan Cancer Drug Therapy Product and Services
Table 10. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Cancer Drug Therapy Major Business
Table 13. Merck Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 14. Merck SWOT Analysis
Table 15. Merck Cancer Drug Therapy Product and Services
Table 16. Merck Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Aveo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 18. Aveo Pharmaceuticals Cancer Drug Therapy Major Business
Table 19. Aveo Pharmaceuticals Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 20. Aveo Pharmaceuticals SWOT Analysis
Table 21. Aveo Pharmaceuticals Cancer Drug Therapy Product and Services
Table 22. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Argos Therapeutics Cancer Drug Therapy Major Business
Table 25. Argos Therapeutics Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 26. Argos Therapeutics SWOT Analysis
Table 27. Argos Therapeutics Cancer Drug Therapy Product and Services
Table 28. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Incyte Basic Information, Manufacturing Base and Competitors
Table 30. Incyte Cancer Drug Therapy Major Business
Table 31. Incyte Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 32. Incyte SWOT Analysis
Table 33. Incyte Cancer Drug Therapy Product and Services
Table 34. Incyte Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca Cancer Drug Therapy Major Business
Table 37. AstraZeneca Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca Cancer Drug Therapy Product and Services
Table 40. AstraZeneca Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 42. Bristol-Myers Squibb Cancer Drug Therapy Major Business
Table 43. Bristol-Myers Squibb Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 44. Bristol-Myers Squibb SWOT Analysis
Table 45. Bristol-Myers Squibb Cancer Drug Therapy Product and Services
Table 46. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Exelixis Basic Information, Manufacturing Base and Competitors
Table 48. Exelixis Cancer Drug Therapy Major Business
Table 49. Exelixis Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 50. Exelixis SWOT Analysis
Table 51. Exelixis Cancer Drug Therapy Product and Services
Table 52. Exelixis Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Bayer Basic Information, Manufacturing Base and Competitors
Table 54. Bayer Cancer Drug Therapy Major Business
Table 55. Bayer Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 56. Bayer SWOT Analysis
Table 57. Bayer Cancer Drug Therapy Product and Services
Table 58. Bayer Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Roche Basic Information, Manufacturing Base and Competitors
Table 60. Roche Cancer Drug Therapy Major Business
Table 61. Roche Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 62. Roche SWOT Analysis
Table 63. Roche Cancer Drug Therapy Product and Services
Table 64. Roche Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Pfizer Basic Information, Manufacturing Base and Competitors
Table 66. Pfizer Cancer Drug Therapy Major Business
Table 67. Pfizer Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 68. Pfizer SWOT Analysis
Table 69. Pfizer Cancer Drug Therapy Product and Services
Table 70. Pfizer Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Eisai Basic Information, Manufacturing Base and Competitors
Table 72. Eisai Cancer Drug Therapy Major Business
Table 73. Eisai Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 74. Eisai SWOT Analysis
Table 75. Eisai Cancer Drug Therapy Product and Services
Table 76. Eisai Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Prometheus Labs Basic Information, Manufacturing Base and Competitors
Table 78. Prometheus Labs Cancer Drug Therapy Major Business
Table 79. Prometheus Labs Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 80. Prometheus Labs SWOT Analysis
Table 81. Prometheus Labs Cancer Drug Therapy Product and Services
Table 82. Prometheus Labs Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Novartis Basic Information, Manufacturing Base and Competitors
Table 84. Novartis Cancer Drug Therapy Major Business
Table 85. Novartis Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 86. Novartis SWOT Analysis
Table 87. Novartis Cancer Drug Therapy Product and Services
Table 88. Novartis Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. Exelixis Basic Information, Manufacturing Base and Competitors
Table 90. Exelixis Cancer Drug Therapy Major Business
Table 91. Exelixis Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 92. Exelixis SWOT Analysis
Table 93. Exelixis Cancer Drug Therapy Product and Services
Table 94. Exelixis Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table 96. Genentech (Roche) Cancer Drug Therapy Major Business
Table 97. Genentech (Roche) Cancer Drug Therapy Total Revenue (USD Million) (2018-2019)
Table 98. Genentech (Roche) SWOT Analysis
Table 99. Genentech (Roche) Cancer Drug Therapy Product and Services
Table 100. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 101. Global Cancer Drug Therapy Sales by Manufacturer (2018-2019) (K Units)
Table 102. Global Cancer Drug Therapy Revenue by Manufacturer (2018-2019) (USD Million)
Table 103. Key Players Cancer Drug Therapy Sales in United States (2018-2019) (K Units)
Table 104. Key Players Cancer Drug Therapy Sales Market Share in United States (2018-2019)
Table 105. Key Players Revenue of Cancer Drug Therapy in United States (2018-2019) (USD Million)
Table 106. Global Cancer Drug Therapy Sales by Regions (2015-2020) (K Units)
Table 107. Global Cancer Drug Therapy Sales Market Share by Regions (2015-2020)
Table 108. Global Cancer Drug Therapy Revenue by Regions (2015-2020) (USD Million)
Table 109. Global Cancer Drug Therapy Sales and Forecast by Regions (2020-2025) (K Units)
Table 110. Global Cancer Drug Therapy Sales Market Share by Regions (2020-2025)
Table 111. Global Cancer Drug Therapy Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 112. Global Cancer Drug Therapy Revenue Market Share by Regions (2020-2025) (USD Million)
Table 113. North America Cancer Drug Therapy Sales by Countries (2015-2020) (K Units)
Table 114. North America Cancer Drug Therapy Sales Market Share by Countries (2015-2020)
Table 115. North America Cancer Drug Therapy Revenue by Countries (2015-2020) (USD Million)
Table 116. North America Cancer Drug Therapy Revenue Market Share by Countries (2015-2020)
Table 117. North America Cancer Drug Therapy Sales by Country (2020-2025) (K Units)
Table 118. North America Cancer Drug Therapy Sales Market Share by Country (2020-2025)
Table 119. North America Cancer Drug Therapy Revenue by Country (2020-2025) (USD Million)
Table 120. North America Cancer Drug Therapy Revenue Market Share by Country (2020-2025)
Table 121. Europe Cancer Drug Therapy Sales by Countries (2015-2020) (K Units)
Table 122. Europe Cancer Drug Therapy Sales Market Share by Countries (2015-2020)
Table 123. Europe Cancer Drug Therapy Revenue by Countries (2015-2020) (USD Million)
Table 124. Europe Cancer Drug Therapy Revenue Market Share by Countries (2015-2020)
Table 125. Europe Cancer Drug Therapy Sales by Country (2020-2025) (K Units)
Table 126. Europe Cancer Drug Therapy Sales Market Share by Country (2020-2025)
Table 127. Europe Cancer Drug Therapy Revenue by Country (2020-2025) (USD Million)
Table 128. Europe Cancer Drug Therapy Revenue Market Share by Country (2020-2025)
Table 129. Asia-Pacific Cancer Drug Therapy Sales by Countries (2015-2020) (K Units)
Table 130. Asia-Pacific Cancer Drug Therapy Sales Market Share by Countries (2015-2020)
Table 131. Asia-Pacific Cancer Drug Therapy Revenue by Countries (2015-2020) (USD Million)
Table 132. Asia-Pacific Cancer Drug Therapy Revenue Market Share by Countries (2015-2020)
Table 133. Asia-Pacific Cancer Drug Therapy Sales by Country (2020-2025) (K Units)
Table 134. Asia-Pacific Cancer Drug Therapy Sales Market Share by Country (2020-2025)
Table 135. Asia-Pacific Cancer Drug Therapy Revenue by Country (2020-2025) (USD Million)
Table 136. Asia-Pacific Cancer Drug Therapy Revenue Market Share by Country (2020-2025)
Table 137. South America Cancer Drug Therapy Sales by Countries (2015-2020) (K Units)
Table 138. South America Cancer Drug Therapy Sales Market Share by Countries (2015-2020)
Table 139. South America Cancer Drug Therapy Revenue by Countries (2015-2020) (USD Million)
Table 140. South America Cancer Drug Therapy Revenue Market Share by Countries (2015-2020)
Table 141. South America Cancer Drug Therapy Sales by Country (2020-2025) (K Units)
Table 142. South America Cancer Drug Therapy Sales Market Share by Country (2020-2025)
Table 143. South America Cancer Drug Therapy Revenue by Country (2020-2025) (USD Million)
Table 144. South America Cancer Drug Therapy Revenue Market Share by Country (2020-2025)
Table 145. Middle East & Africa Cancer Drug Therapy Sales by Countries (2015-2020) (K Units)
Table 146. Middle East & Africa Cancer Drug Therapy Sales Market Share by Countries (2015-2020)
Table 147. Middle East & Africa Cancer Drug Therapy Revenue by Countries (2015-2020) (USD Million)
Table 148. Middle East & Africa Cancer Drug Therapy Revenue Market Share by Countries (2015-2020)
Table 149. Middle East & Africa Cancer Drug Therapy Sales by Country (2020-2025) (K Units)
Table 150. Middle East & Africa Cancer Drug Therapy Sales Market Share by Country (2020-2025)
Table 151. Middle East & Africa Cancer Drug Therapy Revenue by Country (2020-2025) (USD Million)
Table 152. Middle East & Africa Cancer Drug Therapy Revenue Market Share by Country (2020-2025)
Table 153. United States Cancer Drug Therapy Sales by Type (2015-2020) (K Units)
Table 154. United States Cancer Drug Therapy Sales Market Share by Type (2015-2020)
Table 155. United States Cancer Drug Therapy Revenue by Type (2015-2020) (USD Million)
Table 156. United States Cancer Drug Therapy Revenue Market Share by Type (2015-2020)
Table 157. United States Cancer Drug Therapy Sales by Type (2020-2025) (K Units)
Table 158. United States Cancer Drug Therapy Sales Market Share by Type (2020-2025)
Table 159. United States Cancer Drug Therapy Revenue by Type (2020-2025) (USD Million)
Table 160. United States Cancer Drug Therapy Revenue Market Share by Type (2020-2025)
Table 161. Global Cancer Drug Therapy Sales by Application (2015-2020) (K Units)
Table 162. Global Cancer Drug Therapy Sales Market Share by Application (2015-2020)
Table 163. Global Cancer Drug Therapy Revenue by Application (2015-2020) (USD Million)
Table 164. Global Cancer Drug Therapy Revenue Market Share by Application (2015-2020)
Table 165. Global Cancer Drug Therapy Price by Application (2015-2020) (USD/Unit)
Table 166. Global Cancer Drug Therapy Sales by Application (2020-2025) (K Units)
Table 167. Global Cancer Drug Therapy Sales Market Share by Application (2020-2025)
Table 168. Global Cancer Drug Therapy Revenue by Application (2020-2025) (USD Million)
Table 169. Global Cancer Drug Therapy Revenue Market Share by Application (2020-2025)
Table 170. Global Cancer Drug Therapy Price by Application (2020-2025) (USD/Unit)
Table 171. United States Cancer Drug Therapy Sales by Application (2015-2020) (K Units)
Table 172. United States Cancer Drug Therapy Sales Market Share by Application (2015-2020)
Table 173. United States Cancer Drug Therapy Revenue by Application (2015-2020) (USD Million)
Table 174. United States Cancer Drug Therapy Revenue Market Share by Application (2015-2020)
Table 175. United States Cancer Drug Therapy Sales by Application (2020-2025) (K Units)
Table 176. United States Cancer Drug Therapy Sales Market Share by Application (2020-2025)
Table 177. United States Cancer Drug Therapy Revenue by Application (2020-2025) (USD Million)
Table 178. United States Cancer Drug Therapy Revenue Market Share by Application (2020-2025)
Table 179. Direct Channel Pros & Cons
Table 180. Indirect Channel Pros & Cons
Table 181. Distributors/Traders/ Dealers List
Table 182. Customers of Cancer Drug Therapy
Table 183. Market Opportunities in Next Few Years
Table 184. Market Risks Analysis
Table 185. Market Drivers
List of Figures
Figure 1. Cancer Drug Therapy Picture
Figure 2. Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Targeted Therapy Picture
Figure 4. Chemotherapy Picture
Figure 5. Immunotherapy Picture
Figure 6. Cancer Drug Therapy Sales Market Share by Application in 2019
Figure 7. Angiogenesis Inhibitors Picture
Figure 8. mTOR Inhibitors Picture
Figure 9. Monoclonal Antibodies Picture
Figure 10. Cytokine Immunotherapy (IL-2) Picture
Figure 11. Global Cancer Drug Therapy Market Status and Outlook (2015-2025) (USD Million)
Figure 12. Global Cancer Drug Therapy Sales Growth Rate (2015-2025) (K Units)
Figure 13. Global Cancer Drug Therapy Sales Market Share by Manufacturer in 2019
Figure 14. Global Cancer Drug Therapy Revenue Market Share by Manufacturer in 2019
Figure 15. Key Players Cancer Drug Therapy Revenue Market Share in United States in 2019
Figure 16. Global Top 5 Cancer Drug Therapy Manufacturer Market Share in 2019
Figure 17. Top 3 Cancer Drug Therapy Players Market Share in United States in 2019
Figure 18. Global Cancer Drug Therapy Revenue Market Share by Regions in 2019
Figure 19. North America Cancer Drug Therapy Sales YoY Growth (2015-2025) (K Units)
Figure 20. North America Cancer Drug Therapy Revenue YoY Growth (2015-2025) (USD Million)
Figure 21. Europe Cancer Drug Therapy Sales YoY Growth (2015-2020) (K Units)
Figure 22. Europe Cancer Drug Therapy Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. Asia-Pacific Cancer Drug Therapy Sales YoY Growth (2015-2020) (K Units)
Figure 24. Asia-Pacific Cancer Drug Therapy Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. South America Cancer Drug Therapy Sales YoY Growth (2015-2020) (K Units)
Figure 26. South America Cancer Drug Therapy Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. Middle East & Africa Cancer Drug Therapy Sales YoY Growth (2015-2020) (K Units)
Figure 28. Middle East & Africa Cancer Drug Therapy Revenue YoY Growth (2015-2020) (USD Million)
Figure 29. North America Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 30. North America Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 31. United States Cancer Drug Therapy Market Size and Growth Rate (2015-2025) (USD Million)
Figure 32. Canada Cancer Drug Therapy Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Mexico Cancer Drug Therapy Market Size and Growth Rate (2015-2020) (USD Million)
Figure 34. Europe Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 35. Germany Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. United Kingdom Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. France Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Russia Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Italy Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Asia-Pacific Cancer Drug Therapy Sales Market Share by Region 2018
Figure 41. Asia-Pacific Cancer Drug Therapy Revenue Market Share by Region 2018
Figure 42. China Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Japan Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Korea Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. India Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. Southeast Asia Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Australia Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. South America Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 49. South America Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 50. Brazil Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Argentina Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Saudi Arabia Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Turkey Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Egypt Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. South Africa Cancer Drug Therapy Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Global Revenue Market Share of Cancer Drug Therapy by Type in 2019
Figure 57. Global Revenue Market Share of Cancer Drug Therapy by Application in 2019
Figure 58. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Amgen / Allergan
Merck
Aveo Pharmaceuticals
Argos Therapeutics
Incyte
AstraZeneca
Bristol-Myers Squibb
Exelixis
Bayer
Roche
Pfizer
Eisai
Prometheus Labs
Novartis
Exelixis
Genentech (Roche)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets